AB
Abbott Laboratories
ABT · NYSE
$108.32 -0.43% (-$0.47)
1M +0.48%
Market Cap $188.2B
P/E Ratio 34.70x
Div. Yield 2.28%
ROE 10.52%
Bulios Fair Price
$64.71
40.3% downside
Trenutna cena
$108.32
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ABT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
38 /100
Fair P/B 3.68x
P/S 4.04x
P/E 34.70x
Growth
27 /100
Declining Book val. growth 12.42%
FCF growth 1.78%
EPS growth 1.65%
Profitability
86 /100
Strong FCF margin 18.72%
Op. margin 17.03%
Gross margin 56.80%
Quality
40 /100
Average Asset turnover 0.43x
ROA 4.97%
ROIC 6.07%
Debt
68 /100
Low Net debt/EBITDA 2.77x
Int. coverage 12.56x
Debt/Equity 0.64x
Stability
69 /100
Stable Profitable years 6
EPS volatility 98.26%
Beta 0.58x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ABT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert Ford
Employees
115,000
Headquarters
Abbott Park
Prihajajoči dogodki
21 OKT.
Earnings
Upcoming earnings report